1. Home
  2. NUTX vs DAWN Comparison

NUTX vs DAWN Comparison

Compare NUTX & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutex Health Inc.

NUTX

Nutex Health Inc.

HOLD

Current Price

$94.00

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$21.31

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUTX
DAWN
Founded
2011
2018
Country
United States
United States
Employees
944
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
2.2B
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
NUTX
DAWN
Price
$94.00
$21.31
Analyst Decision
Strong Buy
Buy
Analyst Count
2
10
Target Price
$252.50
$26.00
AVG Volume (30 Days)
162.0K
5.8M
Earning Date
06-15-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
7.93
N/A
EPS
10.48
N/A
Revenue
$875,257,000.00
$158,182,000.00
Revenue This Year
$18.71
$53.52
Revenue Next Year
$2.79
$27.10
P/E Ratio
$9.25
N/A
Revenue Growth
82.36
20.60
52 Week Low
$45.88
$5.64
52 Week High
$193.07
$21.40

Technical Indicators

Market Signals
Indicator
NUTX
DAWN
Relative Strength Index (RSI) 39.84 81.71
Support Level $81.70 $6.45
Resistance Level $110.29 $21.40
Average True Range (ATR) 8.37 0.45
MACD 0.33 0.74
Stochastic Oscillator 26.41 99.21

Price Performance

Historical Comparison
NUTX
DAWN

About NUTX Nutex Health Inc.

Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.

Share on Social Networks: